Łukasz W.
- Country
- Poland
- Department
- Oddział Gastroenterologiczny
Research Overview
- A randomized, double-blind, placebo controlled, dose finding study to assess the efficacy and safety of SAR443122 in adult patients with moderate to severe ulcerative colitis
- Efficacy and Safety of Duvakitug for Maintenance Therapy in Participants with Moderately to Severely Active Crohn’s Disease: A Phase 3, Randomized, Placebo-Controlled Study
- Phase II Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Patients with Moderate to Severe Ulcerative Colitis
Data & Insights
Has run more than one trial at 219 of 423 partner sites.
Specializations
Inflammatory Bowel Disease
Clinical research in ulcerative colitis and Crohn’s disease is a central area of interest, with attention to induction and maintenance treatment, symptom control, endoscopic response, and remission in moderate to severe disease. The investigator is also involved in studies addressing treatment targets in active intestinal inflammation and long-term disease control.
- Moderately to severely active ulcerative colitis
- Crohn’s disease
- Endoscopic response
- Clinical remission
Research activity in this domain includes evaluation of advanced therapeutic options for gastrointestinal inflammation and disease complications.
Celiac Disease and Intestinal Mucosal Disease
The investigator is engaged in studies focused on celiac disease, particularly persistent symptoms and mucosal injury despite dietary management. This area reflects interest in improving intestinal healing and symptom relief in chronic immune-mediated enteropathy.
- Celiac disease
- Gluten-free diet–related persistent symptoms
- Mucosal damage
- Symptom improvement
Work in this field supports therapeutic innovation for patients with ongoing small-bowel injury and refractory digestive symptoms.
Cardiovascular Risk and Arterial Hypertension
Clinical involvement also extends to arterial hypertension and prevention of major cardiovascular events in individuals at elevated risk. The investigator’s research landscape includes blood pressure control and reduction of coronary and cerebrovascular outcomes in high-risk patients.
- Arterial hypertension
- High cardiovascular risk
- Myocardial infarction
- Ischemic stroke
This area connects chronic vascular disease management with prevention-oriented therapy.
Infectious Diseases and Respiratory Prevention
Another therapeutic focus is the prevention and treatment of infectious diseases, including influenza, respiratory syncytial virus, pneumococcal infections, and meningococcal infection. The investigator is also involved in work related to severe viral lung disease and complicated bacterial urinary tract infection.
- Influenza
- Respiratory syncytial virus
- Pneumococcal infections
- Complicated urinary tract infection
These studies reflect interest in both prevention and treatment across respiratory and systemic infectious conditions.
Acute Care, Bleeding, and Burn Injury
The investigator is also active in acute therapeutic areas such as emergency management of major bleeding associated with direct oral anticoagulant therapy and wound repair in deep partial and full-thickness burns. This includes interest in hemostatic intervention and skin regeneration.
- Major bleeding
- Direct oral anticoagulant reversal
- Burn wound closure
- Skin grafting
Research in this area supports clinical innovation in urgent care and tissue restoration.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.